The role of the gut microbiota in the development of rheumatic diseases: a focus on fibromyalgia
-
By
-
Yongli Zhao
-
Xingwen Xie
-
July 3, 2026
-
Clinical Scorecard: The Influence of Gut Microbiota on the Onset of Rheumatic Disorders: Emphasizing Fibromyalgia
At a Glance
| Category | Detail |
|---|
| Condition | Fibromyalgia |
| Key Mechanisms | Gut microbiota dysbiosis affecting immune, neuroendocrine, and metabolic pathways. |
| Target Population | Individuals with fibromyalgia, particularly prevalent in women. |
| Care Setting | Rheumatology and chronic pain management. |
Key Highlights
- Fibromyalgia affects 2%–4% of the population and is characterized by chronic widespread pain.
- Gut microbiota dysbiosis is linked to fibromyalgia symptoms and may influence central sensitization.
- Patients with fibromyalgia often exhibit lower microbial diversity and altered metabolite profiles.
- Microbiota-targeted interventions such as probiotics and dietary modifications show preliminary benefits.
- Over half of fibromyalgia patients may also meet criteria for irritable bowel syndrome.
Guideline-Based Recommendations
Diagnosis
- Diagnosis based on clinical symptoms and exclusion of other potential causes.
Management
- Consider microbiota-targeted interventions like probiotics and dietary modifications.
Monitoring & Follow-up
- Monitor changes in gut microbiota composition and clinical symptoms.
Risks
- Potential for systemic inflammation and immune activation in fibromyalgia patients.
Patient & Prescribing Data
Patients diagnosed with fibromyalgia, often with comorbid conditions like IBS.
Microbiota dysbiosis may correlate with pain severity, fatigue, and mental health symptoms.
Clinical Best Practices
- Adopt a holistic view of fibromyalgia considering multifactorial etiology.
- Encourage dietary modifications and consider probiotics as part of management.
Related Resources & Content
